Biotechnology: Global Industry Guide

Product Code MKL14236
Publication Date September 2011
Publisher Marketline
Product Type Report
Pages 218
ISBN Number not applicable
Change currency
PDF £945.00 €1,138 $1,494 BUY >
PRINT £1,010 €1,216 $1,597 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Biotechnology: Global Industry Guide

Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
  • Includes a five-year forecast of the industry

Highlights

The global biotechnology market grew by 8.1% in 2010 to reach a value of $249,969 million.

In 2015, the global biotechnology market is forecast to have a value of $398,236.3 million, an increase of 59.3% since 2010.

Medical/Healthcare is the largest segment of the global biotechnology market, accounting for 67.1% of the market's total value.

Americas accounts for 46.2% of the global biotechnology market value.

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.

Contents

  • ABOUT DATAMONITOR
  • EXECUTIVE SUMMARY
  • INTRODUCTION
    • What is this report about?
    • Who is the target reader?
    • Definitions
  • GLOBAL BIOTECHNOLOGY
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
  • BIOTECHNOLOGY IN ASIA-PACIFIC
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
  • BIOTECHNOLOGY IN EUROPE
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
  • BIOTECHNOLOGY IN FRANCE
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN GERMANY
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN ITALY
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN JAPAN
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN BELGIUM
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN CANADA
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN CHINA
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN THE NETHERLANDS
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN SPAIN
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN THE UNITED KINGDOM
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • BIOTECHNOLOGY IN THE UNITED STATES
    • Market overview
    • Market value
    • Market segmentation I
    • Market segmentation II
    • Five forces analysis
    • Market forecasts
    • Macroeconomic indicators
  • COMPANY PROFILES
    • Astra Zeneca
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc
  • APPENDIX
    • Data Research Methodology
  • LIST OF TABLES
    • Table 1: Global biotechnology market value: $ million, 2006-10
    • Table 2: Global biotechnology market segmentation I:% share, by value, 2010
    • Table 3: Global biotechnology market segmentation II: % share, by value, 2010
    • Table 4: Global biotechnology market value forecast: $ million, 2010-15
    • Table 5: Asia-Pacific biotechnology market value: $ million, 2006-10
    • Table 6: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010
    • Table 7: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010
    • Table 8: Asia-Pacific biotechnology market value forecast: $ million, 2010-15
    • Table 9: Europe biotechnology market value: $ million, 2006-10
    • Table 10: Europe biotechnology market segmentation I:% share, by value, 2010
    • Table 11: Europe biotechnology market segmentation II: % share, by value, 2010
    • Table 12: Europe biotechnology market value forecast: $ million, 2010-15
    • Table 13: France biotechnology market value: $ million, 2006-10
    • Table 14: France biotechnology market segmentation I:% share, by value, 2010
    • Table 15: France biotechnology market segmentation II: % share, by value, 2010
    • Table 16: France biotechnology market value forecast: $ million, 2010-15
    • Table 17: France size of population (million), 2006-10
    • Table 18: France gdp (constant 2000 prices, $ billion), 2006-10
    • Table 19: France gdp (current prices, $ billion), 2006-10
    • Table 20: France inflation, 2006-10
    • Table 21: France consumer price index (absolute), 2006-10
    • Table 22: France exchange rate, 2006-10
    • Table 23: Germany biotechnology market value: $ million, 2006-10
    • Table 24: Germany biotechnology market segmentation I:% share, by value, 2010
    • Table 25: Germany biotechnology market segmentation II: % share, by value, 2010
    • Table 26: Germany biotechnology market value forecast: $ million, 2010-15
    • Table 27: Germany size of population (million), 2006-10
    • Table 28: Germany gdp (constant 2000 prices, $ billion), 2006-10
    • Table 29: Germany gdp (current prices, $ billion), 2006-10
    • Table 30: Germany inflation, 2006-10
    • Table 31: Germany consumer price index (absolute), 2006-10
    • Table 32: Germany exchange rate, 2006-10
    • Table 33: Italy biotechnology market value: $ million, 2006-10
    • Table 34: Italy biotechnology market segmentation I:% share, by value, 2010
    • Table 35: Italy biotechnology market segmentation II: % share, by value, 2010
    • Table 36: Italy biotechnology market value forecast: $ million, 2010-15
    • Table 37: Italy size of population (million), 2006-10
    • Table 38: Italy gdp (constant 2000 prices, $ billion), 2006-10
    • Table 39: Italy gdp (current prices, $ billion), 2006-10
    • Table 40: Italy inflation, 2006-10
    • Table 41: Italy consumer price index (absolute), 2006-10
    • Table 42: Italy exchange rate, 2006-10
    • Table 43: Japan biotechnology market value: $ million, 2006-10
    • Table 44: Japan biotechnology market segmentation I:% share, by value, 2010
    • Table 45: Japan biotechnology market segmentation II: % share, by value, 2010
    • Table 46: Japan biotechnology market value forecast: $ million, 2010-15
    • Table 47: Japan size of population (million), 2006-10
    • Table 48: Japan gdp (constant 2000 prices, $ billion), 2006-10
    • Table 49: Japan gdp (current prices, $ billion), 2006-10
    • Table 50: Japan inflation, 2006-10
    • Table 51: Japan consumer price index (absolute), 2006-10
    • Table 52: Japan exchange rate, 2006-10
    • Table 53: Belgium biotechnology market value: $ million, 2006-10
    • Table 54: Belgium biotechnology market segmentation I:% share, by value, 2010
    • Table 55: Belgium biotechnology market segmentation II: % share, by value, 2010
    • Table 56: Belgium biotechnology market value forecast: $ million, 2010-15
    • Table 57: Belgium size of population (million), 2006-10
    • Table 58: Belgium gdp (constant 2000 prices, $ billion), 2006-10
    • Table 59: Belgium gdp (current prices, $ billion), 2006-10
    • Table 60: Belgium inflation, 2006-10
    • Table 61: Belgium consumer price index (absolute), 2006-10
    • Table 62: Belgium exchange rate, 2006-10
    • Table 63: Canada biotechnology market value: $ million, 2006-10
    • Table 64: Canada biotechnology market segmentation I:% share, by value, 2010
    • Table 65: Canada biotechnology market segmentation II: % share, by value, 2010
    • Table 66: Canada biotechnology market value forecast: $ million, 2010-15
    • Table 67: Canada size of population (million), 2006-10
    • Table 68: Canada gdp (constant 2000 prices, $ billion), 2006-10
    • Table 69: Canada gdp (current prices, $ billion), 2006-10
    • Table 70: Canada inflation, 2006-10
    • Table 71: Canada consumer price index (absolute), 2006-10
    • Table 72: Canada exchange rate, 2006-10
    • Table 73: China biotechnology market value: $ million, 2006-10
    • Table 74: China biotechnology market segmentation I:% share, by value, 2010
    • Table 75: China biotechnology market segmentation II: % share, by value, 2010
    • Table 76: China biotechnology market value forecast: $ million, 2010-15
    • Table 77: China size of population (million), 2006-10
    • Table 78: China gdp (constant 2000 prices, $ billion), 2006-10
    • Table 79: China gdp (current prices, $ billion), 2006-10
    • Table 80: China inflation, 2006-10
    • Table 81: China consumer price index (absolute), 2006-10
    • Table 82: China exchange rate, 2006-10
    • Table 83: Netherlands biotechnology market value: $ million, 2006-10
    • Table 84: Netherlands biotechnology market segmentation I:% share, by value, 2010
    • Table 85: Netherlands biotechnology market segmentation II: % share, by value, 2010
    • Table 86: Netherlands biotechnology market value forecast: $ million, 2010-15
    • Table 87: Netherlands size of population (million), 2006-10
    • Table 88: Netherlands gdp (constant 2000 prices, $ billion), 2006-10
    • Table 89: Netherlands gdp (current prices, $ billion), 2006-10
    • Table 90: Netherlands inflation, 2006-10
    • Table 91: Netherlands consumer price index (absolute), 2006-10
    • Table 92: Netherlands exchange rate, 2006-10
    • Table 93: Spain biotechnology market value: $ million, 2006-10
    • Table 94: Spain biotechnology market segmentation I:% share, by value, 2010
    • Table 95: Spain biotechnology market segmentation II: % share, by value, 2010
    • Table 96: Spain biotechnology market value forecast: $ million, 2010-15
    • Table 97: Spain size of population (million), 2006-10
    • Table 98: Spain gdp (constant 2000 prices, $ billion), 2006-10
    • Table 99: Spain gdp (current prices, $ billion), 2006-10
    • Table 100: Spain inflation, 2006-10
    • Table 101: Spain consumer price index (absolute), 2006-10
    • Table 102: Spain exchange rate, 2006-10
    • Table 103: United Kingdom biotechnology market value: $ million, 2006-10
    • Table 104: United Kingdom biotechnology market segmentation I:% share, by value, 2010
    • Table 105: United Kingdom biotechnology market segmentation II: % share, by value, 2010
    • Table 106: United Kingdom biotechnology market value forecast: $ million, 2010-15
    • Table 107: United Kingdom size of population (million), 2006-10
    • Table 108: United Kingdom gdp (constant 2000 prices, $ billion), 2006-10
    • Table 109: United Kingdom gdp (current prices, $ billion), 2006-10
    • Table 110: United Kingdom inflation, 2006-10
    • Table 111: United Kingdom consumer price index (absolute), 2006-10
    • Table 112: United Kingdom exchange rate, 2006-10
    • Table 113: United States biotechnology market value: $ million, 2006-10
    • Table 114: United States biotechnology market segmentation I:% share, by value, 2010
    • Table 115: United States biotechnology market segmentation II: % share, by value, 2010
    • Table 116: United States biotechnology market value forecast: $ million, 2010-15
    • Table 117: United States size of population (million), 2006-10
    • Table 118: United States gdp (constant 2000 prices, $ billion), 2006-10
    • Table 119: United States gdp (current prices, $ billion), 2006-10
    • Table 120: United States inflation, 2006-10
    • Table 121: United States consumer price index (absolute), 2006-10
    • Table 122: United States exchange rate, 2006-10
    • Table 123: Astra Zeneca: key facts
    • Table 124: Astra Zeneca: key financials ($)
    • Table 125: Astra Zeneca: key financial ratios
    • Table 126: Merck KGaA: key facts
    • Table 127: Merck KGaA: key financials ($)
    • Table 128: Merck KGaA: key financials (€)
    • Table 129: Merck KGaA: key financial ratios
    • Table 130: Novartis AG: key facts
    • Table 131: Novartis AG: key financials ($)
    • Table 132: Novartis AG: key financial ratios
    • Table 133: Pfizer Inc: key facts
    • Table 134: Pfizer Inc: key financials ($)
    • Table 135: Pfizer Inc: key financial ratios
  • LIST OF FIGURES
    • Figure 1: Global biotechnology market value: $ million, 2006-10
    • Figure 2: Global biotechnology market segmentation I:% share, by value, 2010
    • Figure 3: Global biotechnology market segmentation II: % share, by value, 2010
    • Figure 4: Forces driving competition in the global biotechnology market, 2010
    • Figure 5: Drivers of buyer power in the global biotechnology market, 2010
    • Figure 6: Drivers of supplier power in the global biotechnology market, 2010
    • Figure 7: Factors influencing the likelihood of new entrants in the global biotechnology market, 2010
    • Figure 8: Factors influencing the threat of substitutes in the global biotechnology market, 2010
    • Figure 9: Drivers of degree of rivalry in the global biotechnology market, 2010
    • Figure 10: Global biotechnology market value forecast: $ million, 2010-15
    • Figure 11: Asia-Pacific biotechnology market value: $ million, 2006-10
    • Figure 12: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010
    • Figure 13: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010
    • Figure 14: Forces driving competition in the biotechnology market in Asia-Pacific, 2010
    • Figure 15: Drivers of buyer power in the biotechnology market in Asia-Pacific, 2010
    • Figure 16: Drivers of supplier power in the biotechnology market in Asia-Pacific, 2010
    • Figure 17: Factors influencing the likelihood of new entrants in the biotechnology market in Asia-Pacific, 2010
    • Figure 18: Factors influencing the threat of substitutes in the biotechnology market in Asia-Pacific, 2010
    • Figure 19: Drivers of degree of rivalry in the biotechnology market in Asia-Pacific, 2010
    • Figure 20: Asia-Pacific biotechnology market value forecast: $ million, 2010-15
    • Figure 21: Europe biotechnology market value: $ million, 2006-10
    • Figure 22: Europe biotechnology market segmentation I:% share, by value, 2010
    • Figure 23: Europe biotechnology market segmentation II: % share, by value, 2010
    • Figure 24: Forces driving competition in the biotechnology market in Europe, 2010
    • Figure 25: Drivers of buyer power in the biotechnology market in Europe, 2010
    • Figure 26: Drivers of supplier power in the biotechnology market in Europe, 2010
    • Figure 27: Factors influencing the likelihood of new entrants in the biotechnology market in Europe, 2010
    • Figure 28: Factors influencing the threat of substitutes in the biotechnology market in Europe, 2010
    • Figure 29: Drivers of degree of rivalry in the biotechnology market in Europe, 2010
    • Figure 30: Europe biotechnology market value forecast: $ million, 2010-15
    • Figure 31: France biotechnology market value: $ million, 2006-10
    • Figure 32: France biotechnology market segmentation I:% share, by value, 2010
    • Figure 33: France biotechnology market segmentation II: % share, by value, 2010
    • Figure 34: Forces driving competition in the biotechnology market in France, 2010
    • Figure 35: Drivers of buyer power in the biotechnology market in France, 2010
    • Figure 36: Drivers of supplier power in the biotechnology market in France, 2010
    • Figure 37: Factors influencing the likelihood of new entrants in the biotechnology market in France, 2010
    • Figure 38: Factors influencing the threat of substitutes in the biotechnology market in France, 2010
    • Figure 39: Drivers of degree of rivalry in the biotechnology market in France, 2010
    • Figure 40: France biotechnology market value forecast: $ million, 2010-15
    • Figure 41: Germany biotechnology market value: $ million, 2006-10
    • Figure 42: Germany biotechnology market segmentation I:% share, by value, 2010
    • Figure 43: Germany biotechnology market segmentation II: % share, by value, 2010
    • Figure 44: Forces driving competition in the biotechnology market in Germany, 2010
    • Figure 45: Drivers of buyer power in the biotechnology market in Germany, 2010
    • Figure 46: Drivers of supplier power in the biotechnology market in Germany, 2010
    • Figure 47: Factors influencing the likelihood of new entrants in the biotechnology market in Germany, 2010
    • Figure 48: Factors influencing the threat of substitutes in the biotechnology market in Germany, 2010
    • Figure 49: Drivers of degree of rivalry in the biotechnology market in Germany, 2010
    • Figure 50: Germany biotechnology market value forecast: $ million, 2010-15
    • Figure 51: Italy biotechnology market value: $ million, 2006-10
    • Figure 52: Italy biotechnology market segmentation I:% share, by value, 2010
    • Figure 53: Italy biotechnology market segmentation II: % share, by value, 2010
    • Figure 54: Forces driving competition in the biotechnology market in Italy, 2010
    • Figure 55: Drivers of buyer power in the biotechnology market in Italy, 2010
    • Figure 56: Drivers of supplier power in the biotechnology market in Italy, 2010
    • Figure 57: Factors influencing the likelihood of new entrants in the biotechnology market in Italy, 2010
    • Figure 58: Factors influencing the threat of substitutes in the biotechnology market in Italy, 2010
    • Figure 59: Drivers of degree of rivalry in the biotechnology market in Italy, 2010
    • Figure 60: Italy biotechnology market value forecast: $ million, 2010-15
    • Figure 61: Japan biotechnology market value: $ million, 2006-10
    • Figure 62: Japan biotechnology market segmentation I:% share, by value, 2010
    • Figure 63: Japan biotechnology market segmentation II: % share, by value, 2010
    • Figure 64: Forces driving competition in the biotechnology market in Japan, 2010
    • Figure 65: Drivers of buyer power in the biotechnology market in Japan, 2010
    • Figure 66: Drivers of supplier power in the biotechnology market in Japan, 2010
    • Figure 67: Factors influencing the likelihood of new entrants in the biotechnology market in Japan, 2010
    • Figure 68: Factors influencing the threat of substitutes in the biotechnology market in Japan, 2010
    • Figure 69: Drivers of degree of rivalry in the biotechnology market in Japan, 2010
    • Figure 70: Japan biotechnology market value forecast: $ million, 2010-15
    • Figure 71: Belgium biotechnology market value: $ million, 2006-10
    • Figure 72: Belgium biotechnology market segmentation I:% share, by value, 2010
    • Figure 73: Belgium biotechnology market segmentation II: % share, by value, 2010
    • Figure 74: Forces driving competition in the biotechnology market in Belgium, 2010
    • Figure 75: Drivers of buyer power in the biotechnology market in Belgium, 2010
    • Figure 76: Drivers of supplier power in the biotechnology market in Belgium, 2010
    • Figure 77: Factors influencing the likelihood of new entrants in the biotechnology market in Belgium, 2010
    • Figure 78: Factors influencing the threat of substitutes in the biotechnology market in Belgium, 2010
    • Figure 79: Drivers of degree of rivalry in the biotechnology market in Belgium, 2010
    • Figure 80: Belgium biotechnology market value forecast: $ million, 2010-15
    • Figure 81: Canada biotechnology market value: $ million, 2006-10
    • Figure 82: Canada biotechnology market segmentation I:% share, by value, 2010
    • Figure 83: Canada biotechnology market segmentation II: % share, by value, 2010
    • Figure 84: Forces driving competition in the biotechnology market in Canada, 2010
    • Figure 85: Drivers of buyer power in the biotechnology market in Canada, 2010
    • Figure 86: Drivers of supplier power in the biotechnology market in Canada, 2010
    • Figure 87: Factors influencing the likelihood of new entrants in the biotechnology market in Canada, 2010
    • Figure 88: Factors influencing the threat of substitutes in the biotechnology market in Canada, 2010
    • Figure 89: Drivers of degree of rivalry in the biotechnology market in Canada, 2010
    • Figure 90: Canada biotechnology market value forecast: $ million, 2010-15
    • Figure 91: China biotechnology market value: $ million, 2006-10
    • Figure 92: China biotechnology market segmentation I:% share, by value, 2010
    • Figure 93: China biotechnology market segmentation II: % share, by value, 2010
    • Figure 94: Forces driving competition in the biotechnology market in China, 2010
    • Figure 95: Drivers of buyer power in the biotechnology market in China, 2010
    • Figure 96: Drivers of supplier power in the biotechnology market in China, 2010
    • Figure 97: Factors influencing the likelihood of new entrants in the biotechnology market in China, 2010
    • Figure 98: Factors influencing the threat of substitutes in the biotechnology market in China, 2010
    • Figure 99: Drivers of degree of rivalry in the biotechnology market in China, 2010
    • Figure 100: China biotechnology market value forecast: $ million, 2010-15
    • Figure 101: Netherlands biotechnology market value: $ million, 2006-10
    • Figure 102: Netherlands biotechnology market segmentation I:% share, by value, 2010
    • Figure 103: Netherlands biotechnology market segmentation II: % share, by value, 2010
    • Figure 104: Forces driving competition in the biotechnology market in the Netherlands, 2010
    • Figure 105: Drivers of buyer power in the biotechnology market in the Netherlands, 2010
    • Figure 106: Drivers of supplier power in the biotechnology market in the Netherlands, 2010
    • Figure 107: Factors influencing the likelihood of new entrants in the biotechnology market in the Netherlands, 2010
    • Figure 108: Factors influencing the threat of substitutes in the biotechnology market in the Netherlands, 2010
    • Figure 109: Drivers of degree of rivalry in the biotechnology market in the Netherlands, 2010
    • Figure 110: Netherlands biotechnology market value forecast: $ million, 2010-15
    • Figure 111: Spain biotechnology market value: $ million, 2006-10
    • Figure 112: Spain biotechnology market segmentation I:% share, by value, 2010
    • Figure 113: Spain biotechnology market segmentation II: % share, by value, 2010
    • Figure 114: Forces driving competition in the biotechnology market in Spain, 2010
    • Figure 115: Drivers of buyer power in the biotechnology market in Spain, 2010
    • Figure 116: Drivers of supplier power in the biotechnology market in Spain, 2010
    • Figure 117: Factors influencing the likelihood of new entrants in the biotechnology market in Spain, 2010
    • Figure 118: Factors influencing the threat of substitutes in the biotechnology market in Spain, 2010
    • Figure 119: Drivers of degree of rivalry in the biotechnology market in Spain, 2010
    • Figure 120: Spain biotechnology market value forecast: $ million, 2010-15
    • Figure 121: United Kingdom biotechnology market value: $ million, 2006-10
    • Figure 122: United Kingdom biotechnology market segmentation I:% share, by value, 2010
    • Figure 123: United Kingdom biotechnology market segmentation II: % share, by value, 2010
    • Figure 124: Forces driving competition in the biotechnology market in the United Kingdom, 2010
    • Figure 125: Drivers of buyer power in the biotechnology market in the United Kingdom, 2010
    • Figure 126: Drivers of supplier power in the biotechnology market in the United Kingdom, 2010
    • Figure 127: Factors influencing the likelihood of new entrants in the biotechnology market in the United Kingdom, 2010
    • Figure 128: Factors influencing the threat of substitutes in the biotechnology market in the United Kingdom, 2010
    • Figure 129: Drivers of degree of rivalry in the biotechnology market in the United Kingdom, 2010
    • Figure 130: United Kingdom biotechnology market value forecast: $ million, 2010-15
    • Figure 131: United States biotechnology market value: $ million, 2006-10
    • Figure 132: United States biotechnology market segmentation I:% share, by value, 2010
    • Figure 133: United States biotechnology market segmentation II: % share, by value, 2010
    • Figure 134: Forces driving competition in the biotechnology market in the United States, 2010
    • Figure 135: Drivers of buyer power in the biotechnology market in the United States, 2010
    • Figure 136: Drivers of supplier power in the biotechnology market in the United States, 2010
    • Figure 137: Factors influencing the likelihood of new entrants in the biotechnology market in the United States, 2010
    • Figure 138: Factors influencing the threat of substitutes in the biotechnology market in the United States, 2010
    • Figure 139: Drivers of degree of rivalry in the biotechnology market in the United States, 2010
    • Figure 140: United States biotechnology market value forecast: $ million, 2010-15
    • Figure 141: Astra Zeneca: revenues & profitability
    • Figure 142: Astra Zeneca: assets & liabilities
    • Figure 143: Merck KGaA: revenues & profitability
    • Figure 144: Merck KGaA: assets & liabilities
    • Figure 145: Novartis AG: revenues & profitability
    • Figure 146: Novartis AG: assets & liabilities
    • Figure 147: Pfizer Inc: revenues & profitability
    • Figure 148: Pfizer Inc: assets & liabilities